These companies don't just promise future growth—they pay you regularly through substantial dividends. It's like earning interest on your investment while still owning a piece of industry-leading businesses.
Market volatility keeping you up? These established profit machines have weathered economic storms before. Their consistent cash generation and commitment to dividends provide stability when markets get rough.
Reinvesting dividends from these high-yield stocks can supercharge your returns over time. It's the snowball effect that has created wealth for generations of investors who understood the value of dividend income.
We've identified companies that dominate their markets and consistently generate substantial cash. These aren't just profitable businesses—they're corporations with a proven commitment to rewarding shareholders through generous dividends, offering you both growth potential and steady income.
These stocks span diverse sectors—from pharmaceuticals and consumer goods to energy and telecommunications. They serve as portfolio stabilizers during market volatility, providing defensive positioning through their reliable dividend payments while still offering exposure to industry leaders.
Each company was selected after rigorous screening for both profitability and dividend history. We prioritized businesses showing consistent earnings, strong future profit projections, and established patterns of substantial dividend payouts—giving you access to corporate titans that share their success.
These established market leaders don't just generate impressive profits—they're committed to sharing that wealth with you. Carefully selected by our analysts, these dividend powerhouses offer both reliable income streams and the stability of industry-leading businesses.
Market capitalisation breakdown and investor key points for the 'Profit Sharers' basket.
PFE: $141.29B
KO: $306.39B
JNJ: $462.30B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+6
Here are a few of the assets in this group. Create an account to unlock the full list.
12 of 16 assets in this group are rated Buy by professional analysts.
